- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by CG Oncology, Inc.
Total 1005 results
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
CG Oncology, Inc.TerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Bladder Cancer | Carcinoma in Situ Concurrent With Papillary TumorsUnited States
-
CG Oncology, Inc.WithdrawnBladder Cancer | High Grade | Non Muscle InvasiveUnited States
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
CG Oncology, Inc.CompletedSafety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure (BOND2)Bladder CancerUnited States
-
CG Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingNon Muscle Invasive Bladder CancerUnited States, Korea, Republic of
-
CG Pharmaceuticals, IncRecruitingMetastatic Pancreatic AdenocarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCG Oncology, Inc.; Richard M. Shulze Family FoundationActive, not recruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaUnited States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
Taiho Oncology, Inc.RecruitingPancreatic Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Cancer | Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer | Siewert Type 1 GEJ CancerUnited States, Spain, Germany, France
-
Taiho Oncology, Inc.RecruitingNon-Small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Japan, Spain, Germany, Netherlands, United Kingdom
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Kura Oncology, Inc.Recruiting
-
Taiho Oncology, Inc.RecruitingBreast Cancer | Glioblastoma | Solid Tumor | Non-small Cell Lung CancerUnited States, France
-
Mural Oncology, IncRecruitingAdvanced Solid TumorUnited States, Spain
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Kura Oncology, Inc.AvailableHRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
-
Taiho Oncology, Inc.Approved for marketingAdvanced CholangiocarcinomaUnited States
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Rain Oncology IncTerminatedMelanoma | Sarcoma | Cervical Cancer | Testicular Germ Cell Tumor | Gastric Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Lung Adenocarcinoma | Solid Tumors | Pancreas Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Ovarian Carcinoma | Adrenocortical Carcinoma | Bladder Urothelial Carcinoma | Breast... and other conditionsUnited States
-
Rain Oncology IncTerminatedDedifferentiated LiposarcomaUnited States, Spain, France, Korea, Republic of, Taiwan, Canada, Hong Kong, Austria, Germany, Belgium, Georgia, Ireland, Italy, Poland, United Kingdom
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis (PMF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) | Post-polycythemia Vera (Post-PV)United States, Canada, France, Italy, Germany, Spain, Israel, United Kingdom
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Rain Oncology IncTerminatedNSCLC | Non-small Cell Lung Cancer | Non-squamous NSCLCUnited States, Australia
-
Rain Oncology IncTerminatedMetastatic Head-and-neck Squamous-cell CarcinomaUnited States, Australia
-
Taiho Oncology, Inc.Completed
-
Taiho Oncology, Inc.CompletedRefractory Metastatic Gastric CancerFrance, United States, Spain, United Kingdom, Germany, Ireland, Japan, Belgium, Italy, Turkey, Belarus, Israel, Portugal, Russian Federation, Czechia, Poland, Canada, Romania
-
Taiho Oncology, Inc.TerminatedMultiple Myeloma | NonHodgkin LymphomaUnited States
-
Kura Oncology, Inc.CompletedLeukemia, Myelomonocytic, ChronicUnited States
-
Clovis Oncology, Inc.TerminatedLocally Advanced or Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Poland
-
Taiho Oncology, Inc.CompletedColorectal CancerUnited States, Spain, United Kingdom, Australia, Sweden, Belgium, France, Ireland, Germany, Austria, Japan, Italy, Czechia
-
Clovis Oncology, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, France, Germany, Netherlands, Australia, Spain, Taiwan, United Kingdom, Italy
-
Clovis Oncology, Inc.TerminatedSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | NSCLC | Lung Cancer | Metastatic Lung Cancer | SCLC | Stage IV Lung Cancer | Advanced Lung Cancer | Squamous Non-Small Cell Lung CancerUnited States, Italy, Germany, France, Spain
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Sierra Oncology, Inc.TerminatedRelapsed Metastatic KRAS-Mutated Non-Small Cell Lung CancerUnited States
-
K2 Oncology, Inc.Unknown
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States
-
Clovis Oncology, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States, Belgium, Canada, Australia, United Kingdom, Germany, Italy, Argentina, Russian Federation, France, Brazil, Sweden, Norway, Netherlands, Ukraine
-
Taiho Oncology, Inc.WithdrawnAdvanced Hepatocellular Carcinoma
-
Taiho Oncology, Inc.Completed
-
Kura Oncology, Inc.RecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Myeloid Sarcoma | Acute Myeloid Leukemia Recurrent | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute Leukemia | Refractory AML | NPM1 Mutation | Mixed Lineage Leukemia Gene Mutation | AML With Mutated NPM1 | KMT2ArUnited States
-
Pyxis Oncology, IncRecruiting
-
Cullinan Oncology Inc.RecruitingMyelodysplastic Syndrome (MDS) | Relapsed/Refractory Acute Myeloid Leukemia (AML)United States
-
Edgewood Oncology Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Kura Oncology, Inc.RecruitingAcute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Advanced Malignant Neoplasm | Mixed Phenotype Acute Leukemia | Mixed Lineage Leukemia | Mixed Lineage Acute LeukemiaUnited States, Spain, United Kingdom, France, Germany, Canada, Belgium, Italy
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High AmplificationItaly, United States, France, United Kingdom, Spain, Portugal, Canada
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
Kura Oncology, Inc.AvailableAcute Lymphoblastic Leukemia, With Appropriate Mutations | Acute Myeloid Leukemia, With NPM1 Mutations